국소 마취제 시장 : 약제 유형, 유형, 투여 방법, 유통 채널, 최종 용도별 - 세계 예측(2025-2030년)

The Local Anesthesia Drugs Market was valued at USD 2.65 billion in 2023, expected to reach USD 2.80 billion in 2024, and is projected to grow at a CAGR of 5.47%, to USD 3.86 billion by 2030.

Local anesthesia drugs are crucial in numbing specific areas of the body to prevent pain during surgical procedures, dental operations, and other medical interventions. These drugs block nerve conduction, leading to a loss of sensation in peripheral areas without affecting consciousness. The necessity of local anesthesia is underscored by its role in reducing patient discomfort, facilitating minor surgeries, and enhancing outpatient procedures, ultimately contributing to more efficient healthcare delivery. Its application spans across multiple domains including dentistry, ophthalmology, cosmetic surgery, and orthopedic processes, while end-users range from hospitals and clinics to ambulatory surgical centers and individual practitioners.

The market is primarily driven by the increasing prevalence of surgeries due to rising chronic diseases and the growing elderly population, which necessitates low-risk, effective pain management solutions. Technological advancements, such as the development of long-acting local anesthetics, offer potential opportunities to cater to the growing demand for efficient and extended pain relief. Additionally, there's a burgeoning opportunity in developing localized drug delivery systems that reduce systemic side effects, thereby attracting significant attention.

However, the market faces challenges due to stringent regulatory requirements that can delay product approvals and the risk of side effects and allergic reactions in some patients, which can limit wider adoption. Moreover, the COVID-19 pandemic has disrupted supply chains, further complicating market dynamics. Innovating in areas such as biodegradable anesthetics and non-injection delivery methods may drive future growth. Companies should invest in R&D for drugs with fewer side effects and collaborate with medical institutions to better understand real-world efficacy. The market remains competitive and dynamic, requiring players to remain adaptive, ensuring strategic pricing and compliance with regulatory standards to capture sustained growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Local Anesthesia Drugs Market

The Local Anesthesia Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing use of local anesthetic for post-operative pain with rising surgeries across the globe
  • Increase in expansion and approval rate of local anesthesia drugs
• Market Restraints
  • Potential risk associated with the product recall of local anesthetic drugs
• Market Opportunities
  • Integration of nano-based drug delivery systems for effective local anesthetics
  • Investment in R&D for synthetic and non-opioid local anesthetics
• Market Challenges
  • Side effects of local anesthetic drugs

Porter's Five Forces: A Strategic Tool for Navigating the Local Anesthesia Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Local Anesthesia Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Local Anesthesia Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Local Anesthesia Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Local Anesthesia Drugs Market

A detailed market share analysis in the Local Anesthesia Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Local Anesthesia Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Local Anesthesia Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Local Anesthesia Drugs Market

A strategic analysis of the Local Anesthesia Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Local Anesthesia Drugs Market, highlighting leading vendors and their innovative profiles. These include AdvaCare Pharma, Alcon Inc., Anesiva, Inc., Aspen Pharmacare Holdings Limited, AstraZeneca PLC, B. Braun SE, Baxter International, Inc., Boehringer Ingelheim International GmbH, Dentsply Sirona Inc., Eisai Co., Ltd., Endo International PLC, F. Hoffmann-La Roche Ltd., Fresenius SE & Co. KGaA, Heron Therapeutics, Inc., Hikma Pharmaceuticals PLC, ICPA Health Products Limited, Mahendra Chemicals, Merck KGaA, Niksan Pharmaceutical, Novartis AG, Pacira BioSciences, Inc., Pfizer Inc., Pierrel S.p.A., Sagent Pharmaceuticals by Nichi-Iko Pharmaceutical Co., Ltd., Septodont Holding, Teva Pharmaceutical Industries Ltd., Viatris Inc., and Wellona Pharma.

Market Segmentation & Coverage

This research report categorizes the Local Anesthesia Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Drug Type, market is studied across Bupivacaine, Chloroprocaine, Lidocaine, Mepivacaine/ Carbocaine, Prilocaine, and Ropivacaine.
• Based on Type, market is studied across Over-the-Counter and Prescription.
• Based on Mode of Administration, market is studied across Injectable and Surface Anesthetic.
• Based on Distribution Channel, market is studied across Drug Stores/Pharmacies, Hospitals Pharmacies, and Online Retailing.
• Based on End-Use, market is studied across Ambulatory Surgical Centers, Dental Clinics, Hospitals, and Specialty Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing use of local anesthetic for post-operative pain with rising surgeries across the globe
    • 5.1.1.2. Increase in expansion and approval rate of local anesthesia drugs
  • 5.1.2. Restraints
    • 5.1.2.1. Potential risk associated with the product recall of local anesthetic drugs
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of nano-based drug delivery systems for effective local anesthetics
    • 5.1.3.2. Investment in R&D for synthetic and non-opioid local anesthetics
  • 5.1.4. Challenges
    • 5.1.4.1. Side effects of local anesthetic drugs
• 5.2. Market Segmentation Analysis
  • 5.2.1. Drug Type: Advancements to improve the effectiveness, rapid onset, and versatility in the application of lidocaine
  • 5.2.2. Type: Usage of prescription local anesthesia drugs for moderately and highly invasive surgeries
  • 5.2.3. Mode of Administration: Emerging preference for injectable anesthetics in precise applications
  • 5.2.4. Distribution Channel: Critical role played by hospital pharmacies for ensuring immediate and reliable access to local anesthesia drugs in hospital settings
  • 5.2.5. End-Use: Extensive utilization of local anesthesia drugs in hospital settings for diverse surgical operations
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Local Anesthesia Drugs Market, by Drug Type

• 6.1. Introduction
• 6.2. Bupivacaine
• 6.3. Chloroprocaine
• 6.4. Lidocaine
• 6.5. Mepivacaine/ Carbocaine
• 6.6. Prilocaine
• 6.7. Ropivacaine

7. Local Anesthesia Drugs Market, by Type

• 7.1. Introduction
• 7.2. Over-the-Counter
• 7.3. Prescription

8. Local Anesthesia Drugs Market, by Mode of Administration

• 8.1. Introduction
• 8.2. Injectable
• 8.3. Surface Anesthetic

9. Local Anesthesia Drugs Market, by Distribution Channel

• 9.1. Introduction
• 9.2. Drug Stores/Pharmacies
• 9.3. Hospitals Pharmacies
• 9.4. Online Retailing

10. Local Anesthesia Drugs Market, by End-Use

• 10.1. Introduction
• 10.2. Ambulatory Surgical Centers
• 10.3. Dental Clinics
• 10.4. Hospitals
• 10.5. Specialty Clinics

11. Americas Local Anesthesia Drugs Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Local Anesthesia Drugs Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Local Anesthesia Drugs Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Baxter International Inc. Expands the U.S. Pharmaceuticals Portfolio with New Injectable Products
  • 14.3.2. Broadened Applications of ZYNRELEF Enhance Postoperative Pain Management in Diverse Surgical Procedures
  • 14.3.3. Strategic Alliance between Heron Therapeutics and CrossLink Life Sciences to Enhance Distribution of ZYNRELEF
  • 14.3.4. New Patent Issuence for Scilex Holding Company for Its Lead Commercial Product ZTlido (lidocaine topical system)
  • 14.3.5. FDA Approves New Applications for Pacira's EXPAREL Expanding Non-Opioid Pain Management
  • 14.3.6. Strategic Divestiture of Dental Local Anesthetic Portfolio by 3M to Pierrel S.p.A.
  • 14.3.7. Fresenius Kabi Introduces RFID-Enabled Rocuronium Bromide Injection
  • 14.3.8. Sintetica S.A. Expands U.S. Presence with Launch of Lidocaine Hydrochloride Injection Amid National Shortage
  • 14.3.9. Breakthrough in Algae-Based Local Anaesthetic Production through Government-Cawthron Institute Partnership
• 14.4. Strategy Analysis & Recommendation
  • 14.4.1. Aspen Pharmacare Holdings Limited
  • 14.4.2. Baxter International, Inc.
  • 14.4.3. Pacira BioSciences, Inc.
  • 14.4.4. Teva Pharmaceutical Industries Ltd.
  • 14.4.5. Alcon Inc.

Companies Mentioned

• 1. AdvaCare Pharma
• 2. Alcon Inc.
• 3. Anesiva, Inc.
• 4. Aspen Pharmacare Holdings Limited
• 5. AstraZeneca PLC
• 6. B. Braun SE
• 7. Baxter International, Inc.
• 8. Boehringer Ingelheim International GmbH
• 9. Dentsply Sirona Inc.
• 10. Eisai Co., Ltd.
• 11. Endo International PLC
• 12. F. Hoffmann-La Roche Ltd.
• 13. Fresenius SE & Co. KGaA
• 14. Heron Therapeutics, Inc.
• 15. Hikma Pharmaceuticals PLC
• 16. ICPA Health Products Limited
• 17. Mahendra Chemicals
• 18. Merck KGaA
• 19. Niksan Pharmaceutical
• 20. Novartis AG
• 21. Pacira BioSciences, Inc.
• 22. Pfizer Inc.
• 23. Pierrel S.p.A.
• 24. Sagent Pharmaceuticals by Nichi-Iko Pharmaceutical Co., Ltd.
• 25. Septodont Holding
• 26. Teva Pharmaceutical Industries Ltd.
• 27. Viatris Inc.
• 28. Wellona Pharma